← Leaderboards
Ann Cashion
National Institute Of Nursing Research
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute Of Nursing Research
Same institution · by research overlap
Others in their field
Top investigators on “Symptoms”
- Randall J Bateman · Washington University$155,860,406
- Judith S Hochman · New York University School Of Medicine$111,581,511
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$98,224,091
- Eric Martin McDade · Washington University$96,219,353
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
- Monica M Bertagnolli · Strang Cancer Prevention Center$85,994,687
Research focus
SymptomsTechnologyGeneticGene ExpressionPublicationsGenesEnvironmental Risk FactorGenomicsClinical ResearchInflammatoryPainMolecular GeneticsPathway InteractionsNext GenerationScienceBaseMeetingsClinical PracticeBiologicalSeriesFuturePost-Traumatic Stress DisordersAplastic AnemiaReporting
Grant awards (19)
Biomarkers to Predict Patient Outcomes and Guide Therapies$1,803,982
ZIA · FY2019 · NR · contact PI
Genomic Analyses for Elucidating Novel Targets for Symptoms Management$1,443,188
ZIA · FY2019 · NR · contact PI
Biomarkers to Predict Patient Outcomes and Guide Therapies$1,759,005
ZIA · FY2018 · NR · contact PI
Genomic Analyses for Elucidating Novel Targets for Symptoms Management$1,407,203
ZIA · FY2018 · NR · contact PI
Biomarkers to Predict Patient Outcomes and Guide Therapies$2,036,119
ZIA · FY2017 · NR · contact PI
Genomic Analyses for Elucidating Novel Targets for Symptoms Management$1,357,414
ZIA · FY2017 · NR · contact PI
Genomic Analyses for Elucidating Novel Targets for Symptoms Management$1,950,203
ZIA · FY2016 · NR · contact PI
Biomarkers to Predict Patient Outcomes and Guide Therapies$960,547
ZIA · FY2016 · NR · contact PI
Biomarkers to Predict Patient Outcomes and Guide Therapies$1,623,176
ZIA · FY2015 · NR · contact PI
Genomic Analyses for Elucidating Novel Targets for Symptoms Management$811,588
ZIA · FY2015 · NR · contact PI
Biomarkers to Predict Patient Outcomes and Guide Therapies$1,864,614
ZIA · FY2014 · NR · contact PI
NINR Intramural Research Training Programs$932,306
ZIE · FY2014 · NR · contact PI
Genomic Analyses for Elucidating Novel Targets for Symptoms Management$932,306
ZIA · FY2014 · NR · contact PI
NINR Intramural Research Training Programs$1,031,323
ZIE · FY2013 · NR · contact PI
Genomic Analyses for Elucidating Novel Targets for Symptoms Management$618,794
ZIA · FY2013 · NR · contact PI
Molecular-Genetic Mechs Underlying Effects of Anti-inflammatory/Analgesic Drugs$412,529
ZIA · FY2013 · NR · contact PI
Genomic Approaches for Elucidating Novel Targets for Pain and Symptom Management$2,909,970
ZIA · FY2012 · NR · contact PI
Molecular-Genetic Mechs Underlying Effects of Anti-inflammatory/Analgesic Drugs$1,939,980
ZIA · FY2012 · NR · contact PI
NINR Intramural Research Training Programs$748,542
ZIE · FY2012 · NR · contact PI